A research study on Ischemic Cardiomyopathy Evaluation with Coronary Calcium Score and CT Angiogram
Abstract
Aim: This longitudinal study aimed to evaluate the prognostic significance of coronary calcium score and CT angiogram findings in individuals diagnosed with ischemic cardiomyopathy.
Methods: A cohort of patients diagnosed with ischemic cardiomyopathy underwent coronary calcium scoring and CT angiography at baseline. Follow-up assessments were conducted over a period of 1 year from April 2023 to March 2024. Clinical outcomes including cardiac events such as myocardial infarction, hospitalizations due to heart failure exacerbation, and all-cause mortality were recorded and correlated with baseline imaging findings.
Results: The results of the study revealed compelling insights into the prognostic value of coronary calcium scoring and CT angiography in ischemic cardiomyopathy. Individuals having higher coronary calcium scores at baseline demonstrated a greater risk of adverse cardiovascular events and mortality throughout the follow-up period. Similarly, occurrence and extent of coronary artery stenosis detected on CT angiography were strongly associated with adverse outcomes, highlighting its prognostic significance in ischemic cardiomyopathy.
Conclusion: Our findings underscore the prognostic value of coronary calcium score and CT angiogram in risk-stratifying patients with ischemic cardiomyopathy. Integrating these non-invasive imaging modalities into clinical practice could aid in recognizing high-risk people who may benefit from intensified management strategies and closer monitoring.
Keywords: Ischemic cardiomyopathy, coronary calcium score, CT angiogram, prognostic value, longitudinal study, risk stratification.
Published
Issue
Section
License
Copyright (c) 2024 Ibrahim Shah, Akhtar Sher, Matiullah Khan, Saif Ullah, Samiullah Khan, Omer Ibrahim Paracha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.